Convidecia is under clinical development by CanSino Biologics and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

He emphasized that in its current form, HMPV is unlikely to cause severe infections, even amid global concerns of a coronavirus-like outbreak.

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

Discover CDC findings on COVID-19 variants and vaccine protection, revealing key insights into emerging strains and public ...

The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea.

HTI vaccine is under clinical development by Aelix Therapeutics and currently in Phase II for Human Immunodeficiency Virus (HIV) Infections (AIDS).

The World Health Organization (WHO) said that five years ago, its Country Office in China came across a media statement on the Wuhan Municipal Health Commission’s website regarding cases of “viral ...

Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form Type, Route of Administration, Approach, Indication, Packaging - Global ...

Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form Type, Route of Administration, Approach, Indication, Packaging - Global Forecast ...